2126 studies found for:    "Schizophrenia"
Show Display Options
Rank Status Study
1 Unknown  Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Conditions: Schizophrenia, Catatonic;   Schizophrenia, Disorganized;   Schizophrenia, Paranoid;   Schizophrenia;   Psychotic Disorders
Intervention: Drug: Long-acting Risperidone microspheres injection
2 Completed
Has Results
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
Conditions: Schizophrenia;   Schizophrenic Disorders;   Psychotic Disorders;   Dementia Praecox.
Intervention: Drug: Paliperidone ER
3 Completed
Has Results
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Interventions: Drug: asenapine 2.5 mg;   Drug: asenapine 5.0 mg;   Drug: placebo
4 Recruiting Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
Conditions: Schizophrenia;   Schizophrenic Disorder;   Hyperprolactinemia;   Hyperprolactinaemia
Interventions: Drug: PGD granules;   Drug: Placebo
5 Completed Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Intervention: Drug: Sarcosine and D-serine
6 Withdrawn Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Intervention: Drug: Sarcosine (N-methylglycine)
7 Completed MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
Conditions: Paranoid Schizophrenia;   Schizophrenia
Interventions: Drug: MK0557;   Drug: Comparator: Placebo (unspecified)
8 Recruiting Yoga as Cognitive Remediation in Schizophrenia
Conditions: Cognition in Schizophrenia;   Independent Living Skills in Schizophrenia;   Symptoms of Schizophrenia
Interventions: Behavioral: Yoga Training;   Behavioral: Physical Exercise
9 Not yet recruiting RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)
Conditions: Schizophrenia Spectrum Disorder;   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Behavioral: Community-based rehabilitation;   Other: Facility based care
10 Completed A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions
Conditions: Schizophrenia;   Latent Schizophrenia
Intervention:
11 Completed
Has Results
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Intervention: Drug: asenapine
12 Recruiting Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia
Conditions: Refractory Schizophrenia;   Super Refractory Schizophrenia
Interventions: Device: MECTA SPECTRUM 5000Q ECT;   Procedure: Sham ECT
13 Completed Sodium Oxybate in Schizophrenia With Insomnia
Conditions: Schizophrenia;   Insomnia Associated to Schizophrenia
Intervention: Drug: Sodium Oxybate
14 Recruiting A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
Conditions: Schizophrenia;   Schizophrenia-related Psychotic Disorder
Interventions: Drug: Placebo;   Drug: GWP42003
15 Recruiting Pregablin for Anxiety-comorbidity in Patients With Schizophrenia
Conditions: Schizophrenia;   Anxiety-comorbidity to Schizophrenia
Interventions: Drug: Pregabalin;   Drug: Pregabalin Placebo Capsules
16 Completed Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
Conditions: Schizophrenia;   Schizophrenic Disorder
Intervention: Behavioral: Community Re-Entry Program: What is Schizophrenia
17 Completed Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Intervention: Drug: Sarcosine
18 Completed D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Interventions: Drug: D-amino acid oxidase inhibition (DAAOI-1);   Drug: placebo
19 Completed Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia
Conditions: Schizophrenia;   Schizophrenic Disorders;   Psychotic Disorder
Intervention: Drug: paliperidone clozapine
20 Completed Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia
Condition: Schizophrenia
Intervention: Drug: N-Acetyl-Cysteine (NAC)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years